Publications by authors named "Geoffrey Weiss"

Claim this Profile
D
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective Evaluation.
Patricia J Hollen, Richard J Gralla, Ryan D Gentzler, Richard D Hall, Bethany Coyne, Geoffrey Weiss

Oncologist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.
Victor H Engelhard, Rebecca C Obeng, Kara L Cummings, Gina R Petroni, Angela L Ambakhutwala, Geoffrey Weiss

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.
Melanie B Thomas, Elizabeth Garrett-Mayer, Munazza Anis, Kate Anderton, Tricia Bentz, Geoffrey Weiss

Oncology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study of the Self-Reported Resilience of APC Chaplains.
Ronald Oliver, Brian Hughes, Geoffrey Weiss

J Pastoral Care Counsel· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
Howard A Burris, Jeffrey R Infante, Stephen M Ansell, John J Nemunaitis, Geoffrey R Weiss

J Clin Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma NOS1 expression promotes dysfunctional IFN signaling.
Qiuzhen Liu, Sara Tomei, Maria Libera Ascierto, Valeria De Giorgi, Davide Bedognetti, Geoffrey R Weiss

J Clin Invest· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Craig L Slingluff, Gina R Petroni, Kerrington R Molhoek, David L Brautigan, Kimberly A Chianese-Bullock, Geoffrey R Weiss

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.
Patricia J Hollen, Richard J Gralla, Randy A Jones, Christopher Y Thomas, David R Brenin, Geoffrey R Weiss

Support Care Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical management of the patient with metastatic melanoma to the heart.
Joshua M Judge, John D Tillou, Craig L Slingluff, John A Kern, Irving L Kron, Geoffrey R Weiss

J Card Surg· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report.
Robert C Schutt, Trish A Gordon, Ruchi Bhabhra, Helen P Cathro, Stephen L Cook, Geoffrey R Weiss

J Med Case Rep· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
Geoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, Yingdong Zhao, Hui Liu

Clin Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helical tomotherapy-based STAT RT: Dosimetric evaluation for clinical implementation of a rapid radiation palliation program.
Alyson McIntosh, Neal Dunlap, Ke Sheng, Constance Geezey, Benton Turner, Geoffrey Weiss

Med Dosim· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Jayme B Stokes, Norris J Nolan, Edward B Stelow, Dustin M Walters, Geoffrey R Weiss

Ann Surg Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
Alyson McIntosh, Klaus D Hagspiel, Abdullah M Al-Osaimi, Patrick Northup, Stephen Caldwell, Geoffrey Weiss

Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.
Alejandro D Ricart, Anthony W Tolcher, Glenn Liu, Kyle Holen, Garry Schwartz, Geoffrey Weiss

Clin Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
Michael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, Theodore Logan, Joseph I Clark, Geoffrey Weiss

Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.
Joseph M Baisden, Michel Kahaleh, Geoffrey R Weiss, Hilary Sanfey, Christopher A Moskaluk

Gastrointest Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Michel Kahaleh, Rajnish Mishra, Vanessa M Shami, Patrick G Northup, Carl L Berg, Geoffrey R Weiss

Clin Gastroenterol Hepatol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Monica M Mita, Eric K Rowinsky, Leonardo Forero, S Gail Eckhart, Elzbieta Izbicka, Geoffrey R Weiss

Cancer Chemother Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Angela M Davies, Kari Chansky, Derick H M Lau, Bryan R Leigh, Laurie E Gaspar, Geoffrey R Weiss

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
Paul J Hesketh, Jason McCoy, Frank R Dunphy, James D Bearden, Geoffrey R Weiss

J Thorac Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.
Alain C Mita, Lisa A Hammond, Peter L Bonate, Geoffrey Weiss, Heather McCreery

Clin Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024.
Gregory P Swanson, James Faulkner, Stephen R Smalley, Mark J Noble, Ronald L Stephens, Geoffrey R Weiss

J Urol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.
Michael F Sarosdy, Catherine M Tangen, Geoffrey R Weiss, Blake R Nestok, Mitchell C Benson

Urol Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
Javier Hernáandez, Samira Syed, Geoffrey Weiss, Gabriel Fernandes, Dendra von Merveldt

J Urol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis